@ShahidNShah
Heart failure (HF) remains a leading cause of hospitalization and death in Germany, significantly impairing patients’ quality of life (QoL) despite advances in therapy. Structured, multidisciplinary care programs may improve long-term outcomes. HI-PLUS is a pragmatic trial investigating whether a complex intervention can improve QoL in HF patients. We describe the trial design and pilot feasibility study findings.
Advancements in cardiovascular research are improving early detection, treatment precision, and long-term management of heart disease through more personalized care strategies. Growing focus on patient-specific outcomes and innovative cardiac technologies reflects the increasing demand for preventive and data-driven healthcare in the U.S.
Continue reading at link.springer.com
People often recognize what triggered their stress only after the moment has passed. In therapy, this can become a recurring problem: clients are asked to remember what happened between sessions, but …
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2026 Netspective Foundation, Inc. All Rights Reserved.
Built on May 15, 2026 at 3:36pm